As Alzheimer's drug makers abandon today's patients, where is the outrage? - STAT

As Alzheimer's drug makers abandon today's patients, where is the outrage? - STAT

As Alzheimer’s drug developers give up on today’s patients, where is the outrage?

By SHARON BEGLEY

TIM CLARY/AP

Given the 200-plus failed clinical trials of experimental Alzheimer's drugs, companies are now focused on trying to prevent the disease in younger people.

READ MORE